放疗对早期乳腺癌腋窝管理试验的影响
本文综述了早期乳腺癌腋窝管理的主要随机对照试验,重点讨论放疗对试验实施、终点和结论的影响。文章指出手术与放疗均为有效的局部区域治疗手段,但腋窝手术试验中缺乏准确的放疗剂量与靶区评估及稳健的放疗质量保证,导致随机对照试验结果解读存在歧义,并延迟了潜在临床相关结果的实施。
要点
- 腋窝手术试验中缺乏放疗剂量与靶区的准确评估,使随机对照试验结果变得模糊。
- 放疗质量保证不足导致实践差异,并延迟了潜在临床相关结果的实施。
- 综述聚焦放疗对腋窝管理试验的实施、终点与结论的影响。
核心结论
- 腋窝手术随机对照试验中缺乏准确的放疗剂量与靶区评估及稳健的放疗质量保证,使试验结果解读存在歧义。
研究设计与样本
- 本文为综述,讨论旨在确定减少腋窝手术肿瘤学安全性的主要随机对照试验,重点关注放疗对试验实施、终点和结论的影响。
主要发现
- 腋窝淋巴结转移是早期乳腺癌最重要的预后因素之一,但临床和影像学阴性腋窝(cN0)在前哨淋巴结活检(SLNB)后出现阳性淋巴结的管理仍存争议。
- 淋巴结宏转移(>2mm)常被视为腋窝淋巴结清扫(ALND)的指征,但随机研究报告ALND在局部区域复发(LRR)或生存方面无获益,且长期手臂淋巴水肿风险显著。
- 许多中心提供腋窝放疗(ART),但对于低负荷腋窝疾病(1-2枚淋巴结受累)患者是否需要ART仍有争议。
- 手术和放疗(RT)均已被证明是乳腺癌有效的局部区域治疗手段,但腋窝手术试验中缺乏准确的放疗剂量与靶区评估,使随机对照试验(RCT)结果变得模糊。
- 缺乏稳健的放疗质量保证(RTQA)导致了实践差异,肿瘤学界等待验证性试验超过十年,延迟了潜在临床相关结果的实施。
临床怎么用
- 在解读腋窝管理随机对照试验结果时,需考虑放疗剂量与靶区评估的准确性及放疗质量保证的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The presence of metastatic disease in the axillary lymph nodes is one of the most important prognostic factors in early breast cancer1-3 but the management of the clinically and radiologically negative axilla (cN0) with positive nodes following sentinel lymph node biopsy (SLNB) is still a matter of debate. The presence of nodal macrometastases (>2mm) is often regarded as an indication for axillary lymph node dissection (ALND)4 but randomised studies have reported no benefit for ALND in terms of locoregional recurrence (LRR) or survival with a significant risk of long term arm lymphoedema5. As a consequence, many centres offer axillary radiotherapy (ART) but as to whether this is required in patient with low burden axillary disease (1-2 involved nodes) is still debatable. Surgery and radiotherapy (RT) have both demonstrated effectiveness as loco-regional therapies in breast cancer but without accurate assessment of radiation doses and targets in surgical trials of the axilla, results from randomised controlled trials (RCTs) become ambiguous. A lack of robust Radiotherapy Quality Assurance (RTQA) has contributed to variable practice and the oncology community has waited for over a decade for confirmatory trials delaying implementation of potentially clinically relevant results. This review article discusses the main RCTs conducted to determine the oncological safety of reduced axillary surgery with an emphasis on the influence of RT on trial conduct, endpoints and conclusions.
引用
- Oliveros S, Goyal A, Dodwell D, et al. The impact of radiotherapy on trials of axillary management in early breast cancer. Radiother Oncol. 2025. PMID: 40780457. doi:10.1016/j.radonc.2025.111054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。